Robert E Morrow

US Patent:

56745370, Oct 7, 1997

Filed:

Jun 7, 1995

Appl. No.:

8/477293

Inventors:

Robert E. Morrow - Salt Lake City UT

Assignee:

Medical Discoveries, Inc. - Layton UT

International Classification:

A61K 3844
A61K 3500
A61K 3340
A01N 102

US Classification:

424613

Abstract:

A microbiocidal solution for in vivo and in vitro treatment of microbial infections containing an electrolyzed saline solution having a content of regulated amounts of ozone and active chlorine species. The ozone content is 5 to 100 mg/L (milligram per liter) and the chlorine species content is 5 to 300 parts per million (ppm). The active chlorine species comprises free chlorine, hypochlorous acid and the hypochlorite ion as measured by a chlorine selective electrode. The solution is prepared by subjecting a 1% or less saline to electrolysis under conditions sufficient to produce the active ingredients. The solution is used at an isotonic saline concentration and my be adjusted with hypertonic saline. The solution is used in vitro treatments of infected whole blood, blood cells or plasma to reduce contamination. The solution may also be administered to warm blooded animals, including humans by intravenous injection.

US Patent:

56228481, Apr 22, 1997

Filed:

Jul 15, 1994

Appl. No.:

8/275904

Inventors:

Robert E. Morrow - Salt Lake City UT

Assignee:

Medical Discoveries, Inc. - Salt Lake City UT

International Classification:

C12N 1300

US Classification:

4351731

Abstract:

A microbiocidal solution for in vivo and in vitro treatment of microbial infections includes an electrolyzed saline containing regulated amounts of ozone and active chlorine species wherein the ozone content is between about 5 and 100 mg/L and the active chlorine species content of between about 5 and 300 ppm. The active chlorine species comprises free chlorine, hypochlorous acid and the hypochlorite ion as measured by a chlorine selective electrode. The solution is prepared by subjecting a 1% or less saline to electrolysis under conditions sufficient to produce the desired active ingredients. The solution is preferably utilized at an isotonic saline concentration and may be adjusted with hypertonic saline. The solution may be used for the in vitro treatment of infected whole blood, blood cells or plasma to reduce contamination and is effective in treatment of fluids infected with HIV, hepatitis and other viral, bacterial and fungal agents. The solution may also be administered to warm blooded animals, including humans, by intravenous injection or other modes for similar purposes.

US Patent:

53343832, Aug 2, 1994

Filed:

May 23, 1990

Appl. No.:

7/527321

Inventors:

Robert E. Morrow - Salt Lake City UT

Assignee:

Medical Discoveries, Inc. - Logan UT

International Classification:

A61K 3750

US Classification:

424 944

Abstract:

A method of treating antigen related infections is disclosed which comprises subjecting a dilute normal saline solution to electrical hydrolysis with adequate voltage to produce a solution containing bioactive microbicidal atoms, radicals or ions selected from the group consisting of chloride , ozone, hydroxide, hypochlorite, peroxide, chlorine dioxide, and oxygen with corresponding amounts of molecular hydrogen and sodium and hydrogen ions. The solution is balanced to normal saline with hypertonic saline. The injecting of effective amounts of the balanced solution intravenously into a warm blooded animal affected by an antigenic related infection results in a microbicidal action which mimics or enhances action of the free radicals produced in vivo as a result of respiratory bursts. The balanced saline solution may be injected along with the administration of moderating and/or neutralizing amounts of antioxidants or reducing agents such as catalase, superoxide dismutase, MPO or other suitable peroxidase, glutathione, glutathione peroxidase, ascorbic acid or other suitable agents. The moderating antioxidants and/or neutralizing agents are preferably administered orally prior to the administration of the saline solution with additional amounts of ascorbic acid being administered intravenously following injection of the saline.

US Patent:

57310084, Mar 24, 1998

Filed:

Aug 30, 1996

Appl. No.:

8/706218

Inventors:

Robert E. Morrow - Salt Lake City UT

Assignee:

Medical Discoveries, Inc. - Layton UT

International Classification:

A61K 3844
A61K 3340
A61K 3314
C12N 120

US Classification:

424613

Abstract:

A microbiocidal solution for in vivo and in vitro treatment of microbial infections contains an electrolyzed saline containing regulated amounts of ozone and active chlorine species wherein the ozone content is between about 5 and 100 mg/L and the active chlorine species content of between about 5 and 300 ppm. The active chlorine species contains free chlorine, hypochlorous acid and the hypochlorite ion as measured by a chlorine selective electrode. The solution is prepared by subjecting a 1% or less saline to electrolysis under conditions sufficient to produce the desired active ingredients. The solution is preferably utilized at an isotonic saline concentration and may be adjusted with hypertonic saline. The solution may be used for the in vitro treatment of infected whole blood, blood cells or plasma to reduce contamination and is effective in treatment of fluids infected with HIV, hepatitis and other viral, bacterial and fungal agents. The solution may also be administered to warm blooded animals, including humans, by intravenous injection or other modes for similar purposes.